Ona Therapeutics

Ona Therapeutics company information, Employees & Contact Information

Explore related pages

Related company profiles:

Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.

Company Details

Employees
36
Founded
-
Address
Carrer De Baldiri Reixac, 4, Barcelona,catalonia 08028,spain
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Barcelona.
HQ
Barcelona, Catalonia
Looking for a particular Ona Therapeutics employee's phone or email?

Ona Therapeutics Questions

News

Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points - Yahoo Finance

Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points Yahoo Finance

REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment - Business Wire

REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment Business Wire

Reveal genomics, Ona Therapeutics collaborate on ONA-255 to target resistant tumours - FirstWord Pharma

Reveal genomics, Ona Therapeutics collaborate on ONA-255 to target resistant tumours FirstWord Pharma

Why biotech is booming in Barcelona - Nature

Why biotech is booming in Barcelona Nature

Reveal Genomics and Ona link on ONA-255 development for cancer - Pharmaceutical Technology

Reveal Genomics and Ona link on ONA-255 development for cancer Pharmaceutical Technology

Former Algeta CEO named Advancell’s chair-elect - BioCentury

Former Algeta CEO named Advancell’s chair-elect BioCentury

Nature highlights IRB Barcelona spin-offs as biotech trailblazers in Barcelona - Institute for Research in Biomedicine | IRB Barcelona

Nature highlights IRB Barcelona spin-offs as biotech trailblazers in Barcelona Institute for Research in Biomedicine | IRB Barcelona

Aleix Prat: Publishing is not Enough in Biomedical Research - Oncodaily

Aleix Prat: Publishing is not Enough in Biomedical Research Oncodaily

Meet 10 biotech companies you can’t miss in Spain in 2025 - Labiotech.eu

Meet 10 biotech companies you can’t miss in Spain in 2025 Labiotech.eu

Pilatus Biosciences Enters Clinical Collaboration with Roche - European Biotechnology Magazine

Pilatus Biosciences Enters Clinical Collaboration with Roche European Biotechnology Magazine

Up and down the ladder: The latest comings and goings - statnews.com

Up and down the ladder: The latest comings and goings statnews.com

NIH leaders join health agency exodus—Chutes & Ladders - Fierce Biotech

NIH leaders join health agency exodus—Chutes & Ladders Fierce Biotech

A fat-blocking drug could help to fight metastatic cancer - Nature

A fat-blocking drug could help to fight metastatic cancer Nature

How Spain Became Big Pharma’s New Hotspot in Europe - Bloomberg

How Spain Became Big Pharma’s New Hotspot in Europe Bloomberg

Ona raises €30M to treat metastases by blocking fat intake - Fierce Biotech

Ona raises €30M to treat metastases by blocking fat intake Fierce Biotech

The IRB Barcelona spin-off Ona Therapeutics hits the road thanks to Sabadell Asabys - Institute for Research in Biomedicine | IRB Barcelona

The IRB Barcelona spin-off Ona Therapeutics hits the road thanks to Sabadell Asabys Institute for Research in Biomedicine | IRB Barcelona

Ona’s €30m Series A round: directly targeting metastasis in cancer - Pharmaceutical Technology

Ona’s €30m Series A round: directly targeting metastasis in cancer Pharmaceutical Technology

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug - Labiotech.eu

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug Labiotech.eu

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development - Business Wire

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development Business Wire

A drug to block fat intake and combat cancer spread - Nature

A drug to block fat intake and combat cancer spread Nature

Spanish VC closes $200M fund with plan to broaden investments worldwide - Fierce Biotech

Spanish VC closes $200M fund with plan to broaden investments worldwide Fierce Biotech

Disrupting protein folding to tackle cancer - Nature

Disrupting protein folding to tackle cancer Nature

Fierce Biotech's 2020 Fierce 15 - Fierce Biotech

Fierce Biotech's 2020 Fierce 15 Fierce Biotech

Targeting Co-Regulatory Feedback Loop of MYC and GSPT1 By MYC/GSPT1 Dual Degradation Is Synthetic Lethal in Combination with Ven/Aza in TP53 Mutant Acute Myeloid Leukemia Stem and Progenitor Cells - ScienceDirect.com

Targeting Co-Regulatory Feedback Loop of MYC and GSPT1 By MYC/GSPT1 Dual Degradation Is Synthetic Lethal in Combination with Ven/Aza in TP53 Mutant Acute Myeloid Leukemia Stem and Progenitor Cells ScienceDirect.com

Bourla becomes chair of PhRMA - BioCentury

Bourla becomes chair of PhRMA BioCentury

Accelerating drug development with 3D neural models - Nature

Accelerating drug development with 3D neural models Nature

Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data - Fierce Biotech

Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data Fierce Biotech

Top Ona Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant